Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice
Neurobiology of Disease · 2024
DOI: 10.1016/j.nbd.2024.106526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2024. Verfasst von Geoffrey Canet und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laval University, Faculty of Medicine, Neurosciences and Psychiatry department, Québec, QC G1V 0A6, Canada; Neurosciences axis, CHU de Québec Researc…. Hauptthemen laut MEDLINE: Alzheimer Disease, Mice, Transgenic, Streptozocin, tau Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease with a complex origin, thought to involve a combination of genetic, biological and environmental factors. Insulin dysfunction has emerged as a potential factor contributing to AD pathogenesis, particularly in individuals with diabetes, and among those with insulin deficiency or undergoing insulin therapy. The intraperitoneal administration of streptozotocin (STZ) is widely used in rodent models to explore the impact of insulin deficiency on AD pathology, although prior research predominantly focused on young animals, with no comparative analysis across different age groups. Our study aimed to fill this gap by analyzing the impact of insulin dysfunction in 7 and 23 months 3xTg-AD mice, that exhibit both amyloid and tau pathologies. Our objective was to elucidate the age-specific consequences of insulin deficiency on AD pathology. STZ administration led to insulin deficiency in the younger mice, resulting in an increase in cortical amyloid-β (Aβ) and tau aggregation, while tau phosphorylation was not significantly affected. Conversely, older mice displayed an unexpected resilience to the peripheral metabolic impact of STZ, while exhibiting an increase in both tau phosphorylation and aggregation without significantly affecting amyloid pathology. These changes were paralleled with alterations in signaling pathways involving tau kinases and phosphatases. Several markers of blood-brain barrier (BBB) integrity declined with age in 3xTg-AD mice, which might have facilitated a direct neurotoxic effect of STZ in older mice. Overall, our research confirms the influence of insulin signaling dysfunction on AD pathology, but also advises careful interpretation of data related to STZ-induced effects in older animals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laval University, Faculty of Medicine, Neurosciences and Psychiatry department, Québec, QC G1V 0A6, Canada; Neurosciences axis, CHU de Québec Research Center, Québec, QC G1V 4G2, Canada. Electronic address: geoffrey.can…
- Laval University, Faculty of Medicine, Neurosciences and Psychiatry department, Québec, QC G1V 0A6, Canada; Institute of Neurophysiopathology (INP), University of Aix-Marseille, CNRS UMR 7051, 13385 Marseille, France. E…
- Laval University, Faculty of Medicine, Neurosciences and Psychiatry department, Québec, QC G1V 0A6, Canada; Neurosciences axis, CHU de Québec Research Center, Québec, QC G1V 4G2, Canada. Electronic address: charleine.zu…
- Laval University, Faculty of Medicine, Neurosciences and Psychiatry department, Québec, QC G1V 0A6, Canada. Electronic address: mohamed.lala-bouali@crchudequebec.ulaval.ca.
- Laval University, Faculty of Medicine, Neurosciences and Psychiatry department, Québec, QC G1V 0A6, Canada. Electronic address: sofia.diego-diaz.1@ulaval.ca.
- Laval University, Faculty of Medicine, Neurosciences and Psychiatry department, Québec, QC G1V 0A6, Canada. Electronic address: emma.rocaboy.1@ulaval.ca.
Zitieren
APA
Canet, G., Gratuze, M., Zussy, C., Bouali, M. L., Diaz, S. D., Rocaboy, E., Laliberté, F., El Khoury, N. B., Tremblay, C., Morin, F., Calon, F., Hébert, S. S., Julien, C., & Planel, E. (2024). Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106526
Vancouver
Canet G, Gratuze M, Zussy C, Bouali ML, Diaz SD, Rocaboy E, et al. Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2024.106526
BibTeX
@article{Canet2024,
author = {Canet, Geoffrey and Gratuze, Maud and Zussy, Charleine and Bouali, Mohamed Lala and Diaz, Sofia Diego and Rocaboy, Emma and Laliberté, Francis and El Khoury, Noura B and Tremblay, Cyntia and Morin, Françoise and Calon, Frédéric and Hébert, Sébastien S and Julien, Carl and Planel, Emmanuel},
title = {Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice},
journal = {Neurobiology of Disease},
year = {2024},
doi = {10.1016/j.nbd.2024.106526}
}
EUVIMED